Skip to main content

Maria Teresa Mateu Peláez

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Maria Teresa Mateu Peláez

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Related news

The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Related professionals

Abdallah Denial

Abdallah Denial

Maintenance staff and general services
Infectious Diseases
Read more
Maria Luz Uría Oficialdegui

Maria Luz Uría Oficialdegui

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Joan Montaner Villalonga

Joan Montaner Villalonga

Main researcher
Neurovascular Diseases
Read more
Miriam Correa Losada

Miriam Correa Losada

Research technician
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.